vTv Therapeutics approves 1-for-40 reverse stock split to regain Nasdaq compliance

vTv Therapeutics Inc.

Reverse split effective 4:01 PM ET on Nov 20, 2023; post-split trading begins Nov 21.
Ratio 1-for-40 applies equally to Class A and Class B common stock; fractional shares rounded up.
Split intended to regain compliance with Nasdaq $1.00 minimum bid price requirement.
CUSIP for post-split Class A common stock: 91835204; proportionate ownership unchanged.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.